The ADHD medication Vyvanse is facing impending supply issues due to manufacturing delays and increased demand, according to its manufacturer, Takeda Pharmaceuticals. In a statement on the Vyvanse ...
WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Friday approved Shire Plc's stimulant Vyvanse to treat binge-eating disorder, the first product to be approved for the condition.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results